Original scientific paper

Dimitrovska-Ivanova Marija^1,2, Demerdzieva Aneta^2,3 , Karakolevska-Ilova Marija^1,2, Simeonovska-Joveva Elena^1,2, Bezovska Gordica⁴ , Conevska-Jovanova Biljana^2,3, Palcevska Kocevska Snezana^2,3

https://doi.org/10.46733/PESH2514259di

Abstract

Community-acquired pneumonia is one of the most common reasons for paediatric hospitalizations in the world and also in our country. Microbiological indentification is chlallenging, since collection of respiratory samples in chidren is problematic in comparison to adults. Small proportion of children with coomunity acquired pneumonia will develop pleural effusion or empyema. Common causative organisms are Streptococcus pneumoniae and Staphylococcus aureus. Complicated community-acquired pneumonia should be suspected in any child with pneumonia not responding to appropriate antibiotic therapy within 48-72 hours. New conjugated vaccines against Streptococcus pneumoniae have contributed to decreases in radiologic, clinical and complicated pneumonia cases and have reduced hospitalizations and mortality. We report a case of 10 – year old boy with complicated community-acquired pneuminia presented with pleural effusion and pericartidis caused by Streptococcus pneumoniae infection.

Key words: streptococcus pneumonia

__________________________________________

Reference

Harris, M., Clark, J., Coote, N., et al. (2011). British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 66(2):1–23.

Bradley, J. S., Byington, C. L., Shah, S. S., et al. (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis, 53:e25-76.

Donà, D., Brigadoi, G., Grandinetti, R., et al. (2024). Treatment of mild to moderate community-acquired pneumonia in previously healthy children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG-SIMG). Ital J Pediatr, 50(1):217.

Jain, S., Williams, D. J., Arnold, S. R., et al. (2015). Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med, 372:835–845.

Pneumonia Etiology Research for Child Health (PERCH) Study Group. (2019). Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet, 394:757–779.

de Benedictis, F. M., Kerem, E., Chang, . AB., et al. (2020). Complicated pneumonia in children. Lancet, 396:786-98.

Dagan, R., Jacobs, M. R., & Greenberg, D. (2004). Pneumococcal infections- Feigin RD, Cherry JD, Demmler GJ, Kaplan S, editors. Textbook of pediatric infectious diseases, 1. Philadelphia, PA: Saunders Co; 1204-58

Rueda, Z. V., Aguilar, Y., Maya, M. A., et al. (2022). Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents. BMC Pediatr, 22(1):169

Hamouda, S., Chraiet, K., Khalsi, F., et al. (2016). Community-acquired pleuropneumonia in children: Bacteriological and therapeutic challenges. Tunis Med, 94(4):290-297.

Diawara, I., Zerouali, K., Elmdaghri, N., & Abid, A. (2017). A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine. BMC Pediatr, 17(1):114.

Sütçü, M., Aktürk, H., Karagözlü, F., et al. (2017). Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine. Balkan Med J, (1):74-77.

Go, C., Asnis, D. S., & Saltzman, H. (1998). Pneumococcal pericarditis since 1980. Clin Infect Dis, 27(5):1338-40.

Feinstein, Y., Falup-Pecurariu, O., Mitrică, M., et al. (2010). Acute pericarditis caused by Streptococcus pneumoniae in young infants and children: three case reports and a literature review. Int J Infect Dis, 14(2):e175-8.